CertikLabs
Get started

Private preview. CertikLabs is pre-launch. Accreditations, capabilities, and metrics on this page are illustrative targets for the lab we intend to build — not current operational claims.

About CertikLabs · Pre-launch

An independent lab we are building for an industry that finally needs one.

CertikLabs will be a founder-led analytical chemistry laboratory designed for third-party verification of peptide identity, purity, and potency. We will pursue accreditation to ISO/IEC 17025:2017 and will operate under a cGMP-aligned quality system. Accreditation in progress — target 2027.

Planned methods How verification will work
Reference photograph of an analytical chemistry laboratory (illustrative)
Illustrative reference image

Illustrative targets — not current operational metrics

0.01%

HPLC purity resolution (target)

±0.1 Da

Mass accuracy (target)

< 2%

Quantitative CV (target)

2027

Target for full accreditation

01 · Mission

Make trust measurable.

The research-peptide market moves billions of dollars a year on the strength of a PDF emailed from a vendor’s inbox — a document that is trivially edited, frequently fabricated, and almost never re-verified after purchase. Buyers are asked to take quality on faith. Honest brands compete with dishonest ones on equal footing. Regulators have no audit trail.

CertikLabs will replace that PDF with something a buyer, a brand, and a regulator can all check independently: a public verification page tied to a specific physical batch, backed by a sealed Certificate of Analysis whose cryptographic fingerprint is anchored on a public blockchain at the moment of issuance.

Behind that promise will sit a serious laboratory: validated USP <1225> / ICH Q2(R1) methods, NIST-traceable reference standards, redundant orthogonal instrumentation, and a quality manual audited annually by an accrediting body. We are building CertikLabs because the peptide industry deserves the same standard of evidence that small-molecule pharmaceuticals have taken for granted for forty years.

02 · Principles

How we will operate, every day.

Four operating principles that will govern every sample entering our chain-of-custody.

Radical transparency

Every report we will issue is designed to be public by default. The raw chromatograms, the method validation packet, and the SHA-256 anchor record will all be one click away from the verification URL — for anyone, forever.

Independence above all

We will not manufacture, distribute, or resell peptides, and we will hold no equity in any brand we test. Our only product will be the truth printed on the report — including out-of-spec results reported with the same diligence as passing ones.

Methodology you can audit

Every assay will map to a published SOP, a validated method, and a calibrated reference standard traceable to NIST or USP. External auditors will be welcome.

Science without compromise

We plan to invest in the instruments most independent labs cannot justify: high-resolution Orbitrap MS, charged-aerosol detection, and orthogonal confirmatory methods. If two techniques disagree, we will report both.

03 · Planned accreditations

What we intend to hold when the lab is live.

CertikLabs currently holds none of the credentials below. Each is a target for the pre-launch build. We will publish certificate numbers and issuing-body links only after they are actually issued.
Accreditation in progress — target 2027.

ISO/IEC 17025:2017 (planned)

Accreditation in progress — target 2027

We intend to seek accreditation to the international standard for the competence of testing laboratories, covering peptide HPLC purity, LC-MS identity, and quantitative concentration assays.

cGMP-aligned quality system (planned)

Accreditation in progress — target 2027

We will operate a documented Quality Management System mirroring U.S. FDA Current Good Manufacturing Practice (21 CFR Part 211), including validated methods, calibrated reference standards, and chain-of-custody for every sample.

USP <1225> & ICH Q2(R1) method validation (planned)

Accreditation in progress — target 2027

Every method we publish will be validated for specificity, linearity, accuracy, precision, LOD/LOQ, and robustness — and the validation packet will be publicly linkable from the verification page.

Anchored reporting (SHA-256 / public ledger)

Design specification

Every Certificate of Analysis will be hashed and anchored to a public blockchain at issuance so any recipient can independently verify the document has not been altered.

04 · Founder & team

Founder-led. Team to be hired.

CertikLabs is currently a solo founder-led effort. The scientific and quality organization described below is a hiring plan, not a current staff list.

RF

Rob Frye

Founder

Rob is the founder of CertikLabs. Previously he founded and led Xcoins.com (CF Technologies Ltd), a Malta-licensed regulated fiat-to-crypto platform that served more than 400,000 global customers and secured one of the first MFSA Class III VFA licenses issued in 2021. Earlier, he was President & CEO of XBT Holdings, operating a mining and OTC trading business that transacted more than $13M USD. He brings 15+ years of experience building regulated platforms, standing up compliance and AML/KYC programs, and negotiating with financial regulators — the same discipline CertikLabs will apply to laboratory accreditation and evidence-grade batch reporting.

LinkedIn profile

Roles we intend to hire

Scientific Director (PhD Analytical Chemistry)

Own scientific direction across every assay, sign off on method validation packets before release, and represent the lab with USP and pharmacopeial working groups.

Head of Laboratory Operations

Architect chain-of-custody, LIMS, and on-chain anchoring workflows; own end-to-end batch flow from intake seal through anchored Certificate of Analysis.

Director of Mass Spectrometry

Lead the high-resolution LC-MS group, own identity confirmation and impurity profiling methods across GLP-1 analogs, growth-hormone secretagogues, and repair peptides.

Quality Assurance Officer (ISO 17025)

Own the Quality Manual, internal audit calendar, out-of-spec investigation protocol, and act as final signatory on every released report.

Lead HPLC Analyst

Run the HPLC bench, author validated purity methods for target peptides, and mentor junior analysts on system-suitability and integration practices.

Director of Compliance & Chain-of-Custody

Design the tamper-evident sample-intake workflow, own regulator liaison work, and train every analyst on evidence-grade documentation practices.

05 · Commitments

The commitments we will make to every batch.

  • Every Certificate of Analysis will be signed by two qualified analysts and one Quality Assurance Officer.

  • Every report will be hashed (SHA-256) and anchored on a public blockchain within minutes of release.

  • Out-of-spec results will be reported to the brand and made public on the verification page — never quietly suppressed.

  • Brands will not be able to pay to have a failed batch re-tested without a documented root-cause investigation on file.

  • Retention samples will be kept under controlled conditions for a minimum of 24 months for any third-party re-test.

  • Our pricing, methods, and accreditation packets will be public — no NDA required.

Interested in early access when the lab goes live?

CertikLabs is a private preview. Brands, researchers, and prospective hires can request more information ahead of launch.

For brandsHow verification will work

Related

Continue reading

/api

API — Programmatic verification

REST endpoints, webhooks, and SDKs for partners integrating CertikLabs verification into their systems.

Read API — Programmatic verification

/batches

Recent batch verifications — CertikLabs

Browse recent CertikLabs batch verifications. Every batch resolves to a permanent, public verification page with product, vendor, purity, and status.

Read Recent batch verifications — CertikLabs

/capabilities

Lab Capabilities — HPLC, LC-MS, Concentration

Standardized peptide assays: HPLC purity to 0.01%, LC-MS identity (±0.1 Da), quantitative concentration (CV<2%), endotoxin (LAL), and custom methods.

Read Lab Capabilities — HPLC, LC-MS, Concentration